Abstract
Reluctance to make eye contact during natural interactions is a central diagnostic criterion for autism spectrum disorder (ASD). However, the underlying neural correlates for natural eye contacts in ASD are unknown, and diagnostic biomarkers are active areas of investigation. Here, neuroimaging, eye-tracking, and pupillometry data were acquired simultaneously using two-person functional near-infrared spectroscopy (fNIRS) during live eye-to-eye contact and eye-gaze at a video face in typically developed (TD) and ASD participants to identify the neural correlates of live eye-to-eye contact in both groups. Direct comparisons between ASD and TD participants showed decreased right dorsal parietal activity and increased right ventral temporal-parietal activity for ASD relative to TD during live eye-to-eye contact (p≤0.05, FDR-corrected) consistent with the hypothesis of alternative neural systems for live eye contact. The additional hypothesis that hypoactivity of the right dorsal-parietal regions during eye contact is associated with social performance in ASD was supported by the correlation of right dorsal parietal activity with individual measures of social function: ADOS-2, Autism Diagnostic Observation Schedule, 2nd Edition (r = -0.69); and SRS-2, Social Responsiveness Scale, Second Edition (r = -0.58). That is, as social ability decreased, the neural responses in the right dorsal parietal region to real eye-contact also decreased consistent with a neural correlate for social characteristics in ASD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was partially supported by the National Institute of Mental Health of the National Institutes of Health under award numbers 1R01MH111629 (PIs JH and JCM); R01MH107513 (PI JH); 1R01MH119430 (PI JH); U19MH108206 (PI JCM); R01 MH107426 (PI JCM); R01 MH100173 (PI JCM); NIH Medical Scientist Training Program Training Grant T32GM007205 (SD); NRSA 1F30MH116626 (PI SD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All data reported in this paper are available upon request from the corresponding and first author. The authors are grateful to the participants for their essential efforts to advance understanding of ASD; to our two confederates, CD and IS, for consistent partnership with our participants and the investigators; and to Jen Cuzzocreo for data-base management and graphical representations of the data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yale Human Research Protection Program
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets analyzed for this study will be made available upon request at fmri.org/ ENDAR and the NIH Data Archive.
